Stonebridge Financial Group, LLC Rani Therapeutics Holdings, Inc. Transaction History
Stonebridge Financial Group, LLC
- $907 Billion
- Q4 2024
A detailed history of Stonebridge Financial Group, LLC transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Stonebridge Financial Group, LLC holds 100 shares of RANI stock, worth $139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$139% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RANI
# of Institutions
42Shares Held
5.93MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$3.58 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$986,6600.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$686,0811.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$623,4030.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$420,8120.02% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $34M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...